Review of a potential claim of approximately EUR 30 million
|
EQS-Ad-hoc: Nakiki SE / Key word(s): Sales Result/Miscellaneous Nakiki SE announces that a claim of approximately EUR 30 million arising from the supply of COVID masks during the corona pandemic is being examined as part of a litigation financing enquiry. The potential option volume, i.e. the amount to which the company (or the financing subsidiary) is entitled if the litigation financing agreement is concluded and the case is won, is up to EUR 15 million. The Federal Republic of Germany alone, represented by the Federal Ministry of Health, has been sued more than 100 times in connection with the supply of COVID masks, with a value in dispute of more than 1 billion euros. According to press reports, some of these cases have been settled with a partial payment.NAKIKI SE, in future Legal Finance Holding SE End of Inside Information
09-May-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Nakiki SE |
| Johnsallee 30 | |
| 20148 Hamburg | |
| Germany | |
| E-mail: | info@nakikifinance.com |
| Internet: | https://nakikifinance.com/ |
| ISIN: | DE000WNDL300, DE000WNDL318 |
| WKN: | WNDL30, WNDL31 |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1899769 |
| End of Announcement | EQS News Service |
|
|
1899769 09-May-2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.